Key facts about immunoglobulin therapy

1. Immunoglobulin therapies are absolutely essential, lifelong treatments
for the majority of people with primary immunodeficiency (PID).

2. The administration of life-saving immunoglobulin therapies derived from
human plasma provides antibodies which are protective against a
broad range of infections.

3. Immunoglobulin therapies are included in the World Health Organisation (WHO) Lists of Essential Medicines. All countries should provide access to the broadest spectrum of immunoglobulin therapies possible.

4. People with PID rely on the generosity and commitment of plasma and blood
donors. Plasma donations are an essential gift to people in need of immunoglobulins and other plasma-derived medicinal products.

5. There is no alternative therapy for most primary immunodeficiency diseases: immunoglobulin therapies should be prioritised for people with PID.

6. Different modes of administration exist (intravenous immunoglobulin IVIG and subcutaneous immunoglobulin SUBQ), and no single immunoglobulin therapy or delivery method is suitable for all individuals. It is crucial to ensure optimal treatment is provided to people with PID on an individualised basis, tailored to their personal needs.

Posted April 2017